Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Liabilities and Shareholders Equity: 2013-2016

Historic Liabilities and Shareholders Equity for Tvardi Therapeutics (TVRD) over the last 4 years, with Dec 2016 value amounting to $63.8 million.

  • Tvardi Therapeutics' Liabilities and Shareholders Equity rose 34.80% to $108.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $333.1 million, marking a year-over-year decrease of 13.49%. This contributed to the annual value of $63.8 million for FY2016, which is 42.44% down from last year.
  • According to the latest figures from FY2016, Tvardi Therapeutics' Liabilities and Shareholders Equity is $63.8 million, which was down 42.44% from $110.9 million recorded in FY2015.
  • Over the past 5 years, Tvardi Therapeutics' Liabilities and Shareholders Equity peaked at $110.9 million during FY2015, and registered a low of $18.1 million during FY2013.
  • In the last 3 years, Tvardi Therapeutics' Liabilities and Shareholders Equity had a median value of $63.8 million in 2016 and averaged $76.9 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 209.32% in 2014, then crashed by 42.44% in 2016.
  • Tvardi Therapeutics' Liabilities and Shareholders Equity (Yearly) stood at $18.1 million in 2013, then soared by 209.32% to $55.9 million in 2014, then soared by 98.26% to $110.9 million in 2015, then tumbled by 42.44% to $63.8 million in 2016.